Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2851-2860 of 2906 for cancer

Edit search filters
  1. A Comparison Study To Cross-validate The Linear Analogue Self-Assessment (LASA), Patient-Reported Outcomes Measurement Information System (PROMIS), And Patient-reported Outcomes Version Of The Common Terminology Criteria For Adverse Events (PRO-CTCAE) In Assessing Cancer Patient Well-being

    Rochester, MN

  2. Brain Imaging Changes Following Proton Therapy For Pediatric Primary Central Nervous System And Base Of Skull Tumors

    Scottsdale/Phoenix, AZ

  3. Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”)

    Jacksonville, FL

  4. A Registry for the Collection of Biological and Clinical Data for Studies of Immune System Related Blood Disorders

    Rochester, MN

  5. A Study To Measure The Circulating Tumor Cells In The Blood Of The Portal And Hepatic Veins Of The Liver During The Transplant Surgery Of Patients With Liver Cancer

    Rochester, MN

  6. A Study to Evaluate Immune Regulation at the Point Where Maternal Genes and Fetus Genes Meet in the Human Placenta

    Rochester, MN

  7. A Study Of The Natural History Of Monoclonal Gammopathy Of Undetermined Significance (MGUS) Over Time

    Rochester, MN

  8. A Study to Collect Information about Biomarkers (Lab Test Results) that May Help to Predict Which People with Calf Vein Clots May be at Higher or Lower Risk of Having the Clot Grow or Progress

    Rochester, MN

  9. A Study to Create and Maintain Plasma and Serum Bank for Patients with Thrombosis

    Rochester, MN

  10. A Study to Evaluate the Skin Microbiome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

    Jacksonville, FL

.

Mayo Clinic Footer